The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
TLD-1, a novel liposomal doxorubicin, in patients (pts) with advanced solid tumors: Dose escalation and expansion part of a multicenter open-label phase I trial (SAKK 65/16).
 
Dagmar Hess
Stock and Other Ownership Interests - Novartis; Roche
 
Ilaria Colombo
Employment - Medacta (I); Medtronic (I)
Stock and Other Ownership Interests - Medtronic (I)
Honoraria - AstraZeneca (Inst); GlaxoSmithKline (Inst); Novartis (Inst)
Consulting or Advisory Role - MSD Oncology
Research Funding - Bayer (Inst); MSD (Inst); Oasmia Pharmaceutical AB (Inst)
Travel, Accommodations, Expenses - Tesaro
 
Simon Haefliger
Consulting or Advisory Role - AstraZeneca (Inst); Bayer (Inst); Lilly (Inst); Novartis (Inst); Roche (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Amgen
 
Manuela Rabaglio
No Relationships to Disclose
 
Sara Bastian
Consulting or Advisory Role - BMSi; MSD
Research Funding - Bayer
 
Michael Schwitter
Consulting or Advisory Role - AstraZeneca/Daiichi Sankyo; GlaxoSmithKline; Pfizer
 
Katrin Eckhardt
No Relationships to Disclose
 
Jesus Glaus Garzon
No Relationships to Disclose
 
Stefanie Hayoz
No Relationships to Disclose
 
Christoph Kopp
No Relationships to Disclose
 
Lisa Holer
No Relationships to Disclose
 
Anna Mc Laughlin
No Relationships to Disclose
 
Charlotte Kloft
No Relationships to Disclose
 
Cristiana Sessa
Consulting or Advisory Role - Basilea (Inst); IQVIA (Inst)
 
Anastasios Stathis
Consulting or Advisory Role - Bayer (Inst); Lilly (Inst); Novartis (Inst); Roche (Inst)
Research Funding - ADC Therapeutics (Inst); Bayer (Inst); Cellestia Biotech (Inst); Debiopharm Group (Inst); Lilly (Inst); MEI Pharma (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
 
Stefan Halbherr
Employment - InnoMedica
Leadership - InnoMedica
Stock and Other Ownership Interests - InnoMedica
Honoraria - InnoMedica
Consulting or Advisory Role - InnoMedica
Research Funding - InnoMedica
Patents, Royalties, Other Intellectual Property - InnoMedica
Travel, Accommodations, Expenses - InnoMedica
Other Relationship - InnoMedica
 
Christian Baumgartner
Employment - Hirslanden Bern; Medbase Bern
Other Relationship - InnoMedica
 
Markus Joerger
Consulting or Advisory Role - AstraZeneca (Inst); Basilea Pharmaceutical (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Debiopharm Group (Inst); Merck (Inst); Novartis (Inst); Roche (Inst); Sanofi (Inst)
Research Funding - AstraZeneca (Inst); Basilea Pharmaceutical (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); Immunophotonics (Inst); Innomedica (Inst); Janssen Oncology (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst); Roche (Inst); Sanofi (Inst); Takeda (Inst)